The Role of Smoking History in the Efficacy of Neoadjuvant and Perioperative Therapy for Lung Cancer
Cancers · 18.11.2026 · 18 (22) · 3691
DOI: 10.3390/cancers18223691 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 18.11.2026. Verfasst von Aishani S. Gargapati und 2 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Lung cancer is one of the leading causes of cancer-related mortality worldwide, and neoadjuvant therapy has become a cornerstone in the management of resectable non-small-cell lung cancer (NSCLC). Growing evidence suggests that smoking history is an important clinical and biological factor that influences response to neoadjuvant treatment. This review synthesizes epidemiologic, translational, and clinical evidence, including findings from landmark clinical trials. It aims to evaluate the efficacy of neoadjuvant chemotherapy, immunotherapy, targeted therapy, and multimodal treatment strategies according to smoking status. Furthermore, this review examines the molecular and immunologic mechanisms underlying the differential treatment responses observed among current, former, and never-smokers. Ultimately, there is an increasing need to conduct prospective smoking-stratified studies and integrate smoking history into medical practice to develop more personalized neoadjuvant therapies for patients with lung cancer.
Zitieren
APA
Gargapati, A. S., Nixon, K., & Massarelli, E. (2026). The Role of Smoking History in the Efficacy of Neoadjuvant and Perioperative Therapy for Lung Cancer. Cancers, 18(22), 3691. https://doi.org/10.3390/cancers18223691
Vancouver
Gargapati AS, Nixon K, Massarelli E. The Role of Smoking History in the Efficacy of Neoadjuvant and Perioperative Therapy for Lung Cancer. Cancers. 2026;18(22):3691. doi:10.3390/cancers18223691
BibTeX
@article{Gargapati2026,
author = {Gargapati, Aishani S. and Nixon, Kelby and Massarelli, Erminia},
title = {The Role of Smoking History in the Efficacy of Neoadjuvant and Perioperative Therapy for Lung Cancer},
journal = {Cancers},
year = {2026},
volume = {18},
number = {22},
pages = {3691},
doi = {10.3390/cancers18223691}
}
EUVIMED